Adverse Metabolic Effects on Glucose in Patients Receiving Anamorelin Using a Japanese Claims Database.

MLA

Ohta, Hiroaki, et al. “Adverse Metabolic Effects on Glucose in Patients Receiving Anamorelin Using a Japanese Claims Database.” Oncology, vol. 101, no. 12, Dec. 2023, pp. 782–85. EBSCOhost, https://doi.org/10.1159/000533539.

APA

Ohta, H., Horii, T., & Yasu, T. (2023). Adverse Metabolic Effects on Glucose in Patients Receiving Anamorelin Using a Japanese Claims Database. Oncology, 101(12), 782–785. https://doi.org/10.1159/000533539

Chicago

Ohta, Hiroaki, Takeshi Horii, and Takeo Yasu. 2023. “Adverse Metabolic Effects on Glucose in Patients Receiving Anamorelin Using a Japanese Claims Database.” Oncology 101 (12): 782–85. doi:10.1159/000533539.